What Happened? A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides agreed to pause some tariffs for 90 days, signaling a potential turning point in ongoing tensions. This rollback cuts U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. imports to 10%, giving companies breathing room to reset inventories and supply chains. However, President Trump clarified that tariffs could go "substantially higher" if a full deal with China wasn't reached during the 90-day pause, but not all the way back to the previous levels. Still, the agreement has cooled fears of a prolonged trade war, helping stabilize expectations for global growth and trade flows and fueling renewed optimism. The optimism appeared concentrated in key trade-sensitive sectors, particularly technology, retail, and industrials, as lower tariffs reduce cost pressures and restore cross-border demand. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Medical Devices & Supplies - Diversified company Neogen (NASDAQ:NEOG) jumped 9.1%. Is now the time to buy Neogen? Access our full analysis report here, it’s free. Dental Equipment & Technology company Dentsply Sirona (NASDAQ:XRAY) jumped 6%. Is now the time to buy Dentsply Sirona? Access our full analysis report here, it’s free. Hospital Chains company Acadia Healthcare (NASDAQ:ACHC) jumped 8.2%. Is now the time to buy Acadia Healthcare? Access our full analysis report here, it’s free. Hospital Chains company Universal Health Services (NYSE:UHS) jumped 5.9%. Is now the time to buy Universal Health Services? Access our full analysis report here, it’s free. Research Tools & Consumables company Mettler-Toledo (NYSE:MTD) jumped 8.6%. Is now the time to buy Mettler-Toledo? Access our full analysis report here, it’s free. Zooming In On Neogen (NEOG) Neogen’s shares are very volatile and have had 27 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Neogen is down 45.6% since the beginning of the year, and at $6.50 per share, it is trading 63.3% below its 52-week high of $17.71 from July 2024. Investors who bought $1,000 worth of Neogen’s shares 5 years ago would now be looking at an investment worth $202.81. Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. View Comments
Neogen, Dentsply Sirona, Acadia Healthcare, Universal Health Services, and Mettler-Toledo Stocks Trade Up, What You Need To Know
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...